Matches in Wikidata for { <http://www.wikidata.org/entity/Q95172137> ?p ?o ?g. }
Showing items 1 to 39 of
39
with 100 items per page.
- Q95172137 description "clinical trial" @default.
- Q95172137 description "ensayo clínico" @default.
- Q95172137 description "ensayu clínicu" @default.
- Q95172137 description "klinisch onderzoek" @default.
- Q95172137 description "клінічне випробування" @default.
- Q95172137 description "临床试验" @default.
- Q95172137 name "Open-Label Rollover Study for Continuing Valbenazine Administration for the Treatment of Chorea Associated With Huntington Disease" @default.
- Q95172137 name "Open-Label Rollover Study for Continuing Valbenazine Administration for the Treatment of Chorea Associated With Huntington Disease" @default.
- Q95172137 type Item @default.
- Q95172137 label "Open-Label Rollover Study for Continuing Valbenazine Administration for the Treatment of Chorea Associated With Huntington Disease" @default.
- Q95172137 label "Open-Label Rollover Study for Continuing Valbenazine Administration for the Treatment of Chorea Associated With Huntington Disease" @default.
- Q95172137 prefLabel "Open-Label Rollover Study for Continuing Valbenazine Administration for the Treatment of Chorea Associated With Huntington Disease" @default.
- Q95172137 prefLabel "Open-Label Rollover Study for Continuing Valbenazine Administration for the Treatment of Chorea Associated With Huntington Disease" @default.
- Q95172137 P1050 Q95172137-77D94C96-958B-456E-89A4-979F8083756C @default.
- Q95172137 P1132 Q95172137-37A252A8-226D-4A76-991A-C83D3344842B @default.
- Q95172137 P1476 Q95172137-60E61FCD-FE9D-48B7-83AD-5BB576163975 @default.
- Q95172137 P17 Q95172137-6FD49C80-D4B0-41FE-952A-2AC8F02DADFE @default.
- Q95172137 P2899 Q95172137-E04BEE66-C0DE-4867-82A3-F4FA4F9F5B47 @default.
- Q95172137 P3098 Q95172137-D87B7709-3F1D-42AE-99D9-96419AB41D77 @default.
- Q95172137 P31 Q95172137-7942B612-FB13-4085-9175-7B1A61FA65EE @default.
- Q95172137 P4135 Q95172137-3427997E-7089-4DDA-9473-826B1F3581DB @default.
- Q95172137 P580 Q95172137-A87BA0F3-99DB-4939-A790-68909F4B5185 @default.
- Q95172137 P582 Q95172137-42E2F459-DA87-4D26-8BEC-9AA9B1FB9CFA @default.
- Q95172137 P6099 Q95172137-153C662F-BD85-4807-8312-1F5F5122ABCE @default.
- Q95172137 P8005 Q95172137-F81F1C16-C0AD-43C9-992A-CB5EC351ACDE @default.
- Q95172137 P8363 Q95172137-B2D2F6F0-6168-4E32-95FB-024173019E86 @default.
- Q95172137 P1050 Q190564 @default.
- Q95172137 P1132 "+120" @default.
- Q95172137 P1476 "Open-Label Rollover Study for Continuing Valbenazine Administration for the Treatment of Chorea Associated With Huntington Disease" @default.
- Q95172137 P17 Q30 @default.
- Q95172137 P2899 "+18" @default.
- Q95172137 P3098 "NCT04400331" @default.
- Q95172137 P31 Q30612 @default.
- Q95172137 P4135 "+75" @default.
- Q95172137 P580 "2020-07-01T00:00:00Z" @default.
- Q95172137 P582 "2023-07-01T00:00:00Z" @default.
- Q95172137 P6099 Q42824827 @default.
- Q95172137 P8005 Q92331923 @default.
- Q95172137 P8363 Q78089383 @default.